Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$14.72
0.372.58%
At close: Aug 7, 5:00 PM EST
$14.58
0.231.6%
Pre-Market: 8:23 AM EST
Generate Biomedicines Inc (GENB) Stock Price, Quote, News & History
GENBNASDAQ
Earnings: Q2 2026 Earnings were released on Thu Aug 6th, before the market open
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Generate Biomedicines (GENB) stock?
You can purchase shares of Generate Biomedicines (NASDAQ:GENB) through any online brokerage.
Who are Generate Biomedicines (GENB) competitors?
Other companies in Generate Biomedicines’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Generate Biomedicines (GENB) stock?
Generate Biomedicines has a consensus price target of $25.40.
What is the current price for Generate Biomedicines (GENB)?
The stock price for Generate Biomedicines (NASDAQ: GENB) is $14.58 last updated August 11, 2026 at 7:40 AM EDT.
Does Generate Biomedicines (GENB) pay a dividend?
There are no upcoming dividends for Generate Biomedicines.
When is Generate Biomedicines (NASDAQ:GENB) reporting earnings?
Generate Biomedicines does not have any upcoming earnings scheduled.
Is Generate Biomedicines (GENB) going to split?
There is no upcoming split for Generate Biomedicines.
What sector and industry does Generate Biomedicines (GENB) operate in?
Generate Biomedicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
